168 filings
Page 3 of 9
6-K
py7fjkq08vr2whopsp3x
14 Apr 23
GENFIT Reports Full-Year 2022 Financial Results and Provides Corporate Update
7:00am
6-K
crnyvu7oyxuk
28 Feb 23
Current report (foreign)
4:10pm
6-K
r3m3k0xs fml
30 Jan 23
Current report (foreign)
4:10pm
6-K
425czapzoudxk rv1
24 Jan 23
GENFIT Announces 2023 Financial Calendar
4:10pm
6-K
o4efxdt2 eg46jv
5 Jan 23
GENFIT to Participate in Upcoming Investor Conferences
4:10pm
6-K
8otmurar 94
17 Nov 22
GENFIT Pipeline Day Highlights Diverse Product Portfolio in Underserved Liver Diseases
4:10pm
6-K
rxo15 lls0
10 Nov 22
GENFIT Reports Third Quarter 2022 Financial Information
4:10pm
6-K
qi4mhl
25 Oct 22
Current report (foreign)
4:10pm
6-K
vuvykm
29 Sep 22
GENFIT Announces Signature of the Share Purchase Agreement and the Completion of its Acquisition of Versantis
4:10pm
6-K
jjn95er kz888
28 Sep 22
GENFITÂ Reports First Half-Year 2022 Financial Results and Provides Corporate Update
4:13pm
6-K
mnhlsuiyj7o0vjzsue
19 Sep 22
GENFIT to Acquire Clinical-stage Biopharmaceutical Company Versantis, expanding its Portfolio in Liver Diseases
6:10am
6-K
bficvt wvrjgqmyrrb
13 Sep 22
FDA Grants GENFIT’s GNS561 Orphan Drug Designation for the Treatment of Cholangiocarcinoma
4:15pm
6-K
137klxydt6pp9jzz
8 Jul 22
Current report (foreign)
4:15pm
6-K
a6mcsqlfc920nkfmoz2d
25 May 22
Current report (foreign)
4:10pm
6-K
fy8rob6pieys94cl4gq
11 May 22
GENFIT Reports First Quarter 2022 Financial Information
4:10pm
6-K
ctsqrr49bs
29 Apr 22
GENFIT Announces Publication of the 2021 Universal
4:10pm
6-K
eepjyvtk
27 Apr 22
Shareholders' and Unitholders' Meetings
9:43am
6-K
h9z28
20 Apr 22
Current report (foreign)
4:10pm